Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:43:27.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Access to the study record has been replaced by a 403 Forbidden error page, effectively removing the study details and navigation from view. The page now shows a standard 403 message along with site chrome (Home link and footer).
    Difference
    21%
    Check dated 2026-09-20T20:32:02.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Related topics were added to the page, including a 'Multiple myeloma' entry and a MedlinePlus Genetics link, under the related topics section to aid navigation.
    Difference
    0.1%
    Check dated 2026-09-06T22:33:27.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Footer text updated to Revision: v3.6.6; deleted older references to 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the previous revision tag 'Revision: v3.6.5'.
    Difference
    0.2%
    Check dated 2026-08-30T22:41:41.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed as a topic on the page, and a Related topics entry for MedlinePlus Genetics has been added.
    Difference
    0.1%
    Check dated 2026-08-23T19:56:47.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    - Removed the 'Multiple myeloma' label and the 'MedlinePlus Genetics' link from the related topics area. This reduces disease-specific context and removes a genetics resource for users.
    Difference
    0.1%
    Check dated 2026-08-16T16:31:33.000Z thumbnail image

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.